missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18172552

CDC123 Antibody (OTI1F8), DyLight 488, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-71391G

Product Code. 18172552

  • € 751.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CDC123 Monoclonal specifically detects CDC123 in Human, Mouse, Rat, Canine, Monkey samples. It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CDC123
Monoclonal
DyLight 488
50mM Sodium Borate with 0.05% Sodium Azide
CDC123
Full length recombinant protein of human CDC123 (NP_006014) produced in HEK293T cells.
0.1 mL
Primary
Human, Mouse, Rat, Canine, Monkey
IgG2a
Western Blot, Immunohistochemistry, Immunocytochemistry, Immunofluorescence
OTI1F8
Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence
cell division cycle 123 homolog (S. cerevisiae), cell division cycle protein 123 homolog, chromosome 10 open reading frame 7, D123C10orf7, FLJ13863, HT-1080, Protein D123, PZ32
Mouse
Affinity Purified
Cell Cycle and Replication
8872.0
Store at 4°C in the dark.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.